Publications of Axel Ullrich

Journal Article (154)

21.
Journal Article
Gärtner, S.; Gunesch, A.; Knyazeva, T.; Wolf, P.; Högel, B.; Eiermann, W.; Ullrich, A.; Knyazev, P.; Ataseven, B.: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement. PLOS ONE 9 (1), e84472 (2014)
22.
Journal Article
Paolino, M.; Choidas, A.; Wallner, S.; Pranjic, B.; Uribesalgo, I.; Loeser, S.; Jamieson, A. M.; Langdon, W. Y.; Ikeda, F.; Fededa, J. P. et al.; Cronin, S. J.; Nitsch, R.; Schultz-Fademrecht, C.; Eickhoff, J.; Menninger, S.; Unger, A.; Torka, R.; Gruber, T.; Hinterleitner, R.; Baier, G.; Wolf, D.; Ullrich, A.; Klebl, B. M.; Penninger, J. M.: The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. NATURE 507 (7493), pp. 508 - 512 (2014)
23.
Journal Article
Penzes, K.; Baumann, C.; Szabadkai, I.; Orfi, L.; Keri, G.; Ullrich, A.; Torka, R.: Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells. CANCER BIOLOGY & THERAPY 15 (11), pp. 1571 - 1582 (2014)
24.
Journal Article
Tan, D. S. W.; Haaland, B.; Gan, J. M.; Tham, S. C.; Sinha, I.; Tan, E. H.; Lim, K. H.; Takano, A.; Krisna, S. S.; Thu, M. M. M. et al.; Liew, H. P.; Ullrich, A.; Lim, W.-T.; Chua, B. T.: Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer. MOLECULAR CANCER 13, 13 (2014)
25.
Journal Article
Xiao, Z.; Sperl, B.; Ullrich, A.; Knyazev, P.: Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. ONCOTARGET 5 (24), pp. 12877 - 12890 (2014)
26.
Journal Article
Zanucco, E.; El-Nikhely, N.; Goetz, R.; Weidmann, K.; Pfeiffer, V.; Savai, R.; Seeger, W.; Ullrich, A.; Rapp, U. R.: Elimination of B-RAF in Oncogenic C-RAF-expressing Alveolar Epithelial Type II Cells Reduces MAPK Signal Intensity and Lung Tumor Growth. JOURNAL OF BIOLOGICAL CHEMISTRY 289 (39), pp. 26804 - 26816 (2014)
27.
Journal Article
Stampolidis, P.; Ullrich, A.; Iacobelli, S.: LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention. Oncogene, pp. 1 - 14 (2013)
28.
Journal Article
Gusenbauer, S.; Vlaicu, P.; Ullrich, A.: HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors. Oncogene, pp. 1 - 11 (2013)
29.
Journal Article
Vlaicu, P.; Mertins, P.; Mayr, T.; Widschwendter, P.; Ataseven, B.; Hogel, B.; Eiermann, W.; Knyazev, P.; Ullrich, A.: Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator. BMC CANCER 13, 197 (2013)
30.
Journal Article
Ho, H. K.; Nemeth, G.; Ng, Y. R.; Pang, E.; Szantai-Kis, C.; Zsakai, L.; Breza, N.; Greff, Z.; Horvath, Z.; Pato, J. et al.; Szabadkai, I.; Szokol, B.; Baska, F.; Orfi, L.; Ullrich, A.; Keri, G.; Chua, B. T.: Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing. CURRENT MEDICINAL CHEMISTRY 20 (10), pp. 1203 - 1217 (2013)
31.
Journal Article
Kaneta, Y.; Ullrich, A.: NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 442 (3-4), pp. 139 - 146 (2013)
32.
Journal Article
Piccolo, E.; Tinari, N.; Semeraro, D.; Traini, S.; Fichera, I.; Cumashi, A.; La Sorda, R.; Spinella, F.; Bagnato, A.; Lattanzio, R. et al.; D'Egidio, M.; Di Risio, A.; Stampolidis, P.; Piantelli, M.; Natoli, C.; Ullrich, A.; Iacobelli, S.: LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. JOURNAL OF MOLECULAR MEDICINE-JMM 91 (1), pp. 83 - 94 (2013)
33.
Journal Article
Oak, P. S.; Kopp, F.; Thakur, C.; Ellwart, J. W.; Rapp, U. R.; Ullrich, A.; Wagner, E.; Knyazev, P.; Roidl, A.: Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells. INTERNATIONAL JOURNAL OF CANCER 131 (12), pp. 2808 - 2819 (2012)
34.
Journal Article
Bezler, M.; Hengstler, J. G.; Ullrich, A.: Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. Molecular Oncology 6 (5), pp. 516 - 529 (2012)
35.
Journal Article
Bender, C.; Ullrich, A.: PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines. International Journal of Cancer 131 (2), pp. E45 - E55 (2012)
36.
Journal Article
Beji, A.; Horst, D.; Engel, J.; Kirchner, T.; Ullrich, A.: Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer. Clinical Cancer Research 18 (4), pp. 956 - 968 (2012)
37.
Journal Article
Keri, G.; Ullrich, A.: PREFACE. Current Signal Transduction Therapy 7 (1), p. 1 - 1 (2012)
38.
Journal Article
Tateno, T.; Asa, S. L.; Zheng, L.; Mayr, T.; Ullrich, A.; Ezzat, S.: The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis. PLoS Genetics 7 (12), e1002400, p. e1002400 - e1002400 (2011)
39.
Journal Article
Alokail, M. S.; Al-Daghri, N. M.; Al-Attas, O. S.; Alkharfy, K. M.; Sabico, S. B.; Ullrich, A.: Visceral obesity and inflammation markers in relation to serum prostate volume biomarkers among apparently healthymen. European Journal of Clinical Investigation 41 (9), pp. 987 - 994 (2011)
40.
Journal Article
Ullrich, A.: From Genes to Cancer Therapies. European Journal of Cancer 47 (Suppl. 1), p. S54 - S54 (2011)
Go to Editor View